Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells.
Peereboom DM, Alban TJ, Grabowski MM, Alvarado AG, Otvos B, Bayik D, Roversi G, McGraw M, Huang P, Mohammadi AM, Kornblum HI, Radivoyevitch T, Ahluwalia MS, Vogelbaum MA, Lathia JD. Peereboom DM, et al. Among authors: mcgraw m. JCI Insight. 2019 Nov 14;4(22):e130748. doi: 10.1172/jci.insight.130748. JCI Insight. 2019. PMID: 31600167 Free PMC article. Clinical Trial.
Results of the NeuroBlate System first-in-humans Phase I clinical trial for recurrent glioblastoma: clinical article.
Sloan AE, Ahluwalia MS, Valerio-Pascua J, Manjila S, Torchia MG, Jones SE, Sunshine JL, Phillips M, Griswold MA, Clampitt M, Brewer C, Jochum J, McGraw MV, Diorio D, Ditz G, Barnett GH. Sloan AE, et al. Among authors: mcgraw mv. J Neurosurg. 2013 Jun;118(6):1202-19. doi: 10.3171/2013.1.JNS1291. Epub 2013 Apr 5. J Neurosurg. 2013. PMID: 23560574 Clinical Trial.
Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer.
Andersson U, Wibom C, Cederquist K, Aradottir S, Borg A, Armstrong GN, Shete S, Lau CC, Bainbridge MN, Claus EB, Barnholtz-Sloan J, Lai R, Il'yasova D, Houlston RS, Schildkraut J, Bernstein JL, Olson SH, Jenkins RB, Lachance DH, Wrensch M, Davis FG, Merrell R, Johansen C, Sadetzki S; Gliogene Consortium; Bondy ML, Melin BS. Andersson U, et al. Neuro Oncol. 2014 Oct;16(10):1333-40. doi: 10.1093/neuonc/nou052. Epub 2014 Apr 9. Neuro Oncol. 2014. PMID: 24723567 Free PMC article.
Correlation of higher levels of soluble TNF-R1 with a shorter survival, independent of age, in recurrent glioblastoma.
Ahluwalia MS, Bou-Anak S, Burgett ME, Sarmey N, Khosla D, Dahiya S, Weil RJ, Bae E, Huang P, McGraw M, Grove LM, Olman MA, Prayson RA, Suh JH, Gillespie GY, Barnholtz-Sloan J, Nowacki AS, Barnett GH, Gladson CL. Ahluwalia MS, et al. Among authors: mcgraw m. J Neurooncol. 2017 Feb;131(3):449-458. doi: 10.1007/s11060-016-2319-2. Epub 2016 Nov 17. J Neurooncol. 2017. PMID: 27858267 Free PMC article.
Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis.
Alban TJ, Alvarado AG, Sorensen MD, Bayik D, Volovetz J, Serbinowski E, Mulkearns-Hubert EE, Sinyuk M, Hale JS, Onzi GR, McGraw M, Huang P, Grabowski MM, Wathen CA, Ahluwalia MS, Radivoyevitch T, Kornblum HI, Kristensen BW, Vogelbaum MA, Lathia JD. Alban TJ, et al. Among authors: mcgraw m. JCI Insight. 2018 Nov 2;3(21):e122264. doi: 10.1172/jci.insight.122264. JCI Insight. 2018. PMID: 30385717 Free PMC article.
Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner.
Bayik D, Zhou Y, Park C, Hong C, Vail D, Silver DJ, Lauko A, Roversi G, Watson DC, Lo A, Alban TJ, McGraw M, Sorensen M, Grabowski MM, Otvos B, Vogelbaum MA, Horbinski C, Kristensen BW, Khalil AM, Hwang TH, Ahluwalia MS, Cheng F, Lathia JD. Bayik D, et al. Among authors: mcgraw m. Cancer Discov. 2020 Aug;10(8):1210-1225. doi: 10.1158/2159-8290.CD-19-1355. Epub 2020 Apr 16. Cancer Discov. 2020. PMID: 32300059 Free PMC article.
Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell Subsets.
Bayik D, Bartels CF, Lovrenert K, Watson DC, Zhang D, Kay K, Lee J, Lauko A, Johnson S, Lo A, Silver DJ, McGraw M, Grabowski M, Mohammadi AM, Veglia F, Fan Y, Vogelbaum MA, Scacheri P, Lathia JD. Bayik D, et al. Among authors: mcgraw m. Cancer Res. 2022 Nov 15;82(22):4274-4287. doi: 10.1158/0008-5472.CAN-21-3840. Cancer Res. 2022. PMID: 36126163 Free PMC article.
The MIF promoter SNP rs755622 is associated with immune activation in glioblastoma.
Alban TJ, Grabowski MM, Otvos B, Bayik D, Wang W, Zalavadia A, Makarov V, Troike K, McGraw M, Rabljenovic A, Lauko A, Neumann C, Roversi G, Waite KA, Cioffi G, Patil N, Tran TT, McCortney K, Steffens A, Diaz CM, Brown JM, Egan KM, Horbinski CM, Barnholtz-Sloan JS, Rajappa P, Vogelbaum MA, Bucala R, Chan TA, Ahluwalia MS, Lathia JD. Alban TJ, et al. Among authors: mcgraw m. JCI Insight. 2023 Jul 10;8(13):e160024. doi: 10.1172/jci.insight.160024. JCI Insight. 2023. PMID: 37252795 Free PMC article.
Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in Glioblastoma.
Lee J, Nicosia M, Hong ES, Silver DJ, Li C, Bayik D, Watson DC, Lauko A, Kay KE, Wang SZ, Johnson S, McGraw M, Grabowski MM, Kish DD, Desai AB, Goodman WA, Cameron SJ, Okada H, Valujskikh A, Fairchild RL, Ahluwalia MS, Lathia JD. Lee J, et al. Among authors: mcgraw m. Cancer Discov. 2023 Sep 6;13(9):2090-2105. doi: 10.1158/2159-8290.CD-22-0869. Cancer Discov. 2023. PMID: 37378557 Free PMC article.
Family history of cancer in benign brain tumor subtypes versus gliomas.
Ostrom QT, McCulloh C, Chen Y, Devine K, Wolinsky Y, Davitkov P, Robbins S, Cherukuri R, Patel A, Gupta R, Cohen M, Vengoechea Barrios J, Brewer C, Schilero C, Smolenski K, McGraw M, Denk B, Naska T, Laube F, Steele R, Greene D, Kastl A, Bell S, Aziz D, Chiocca EA, McPherson C, Warnick R, Barnett GH, Sloan AE, Barnholtz-Sloan JS. Ostrom QT, et al. Among authors: mcgraw m. Front Oncol. 2012 Feb 28;2:19. doi: 10.3389/fonc.2012.00019. eCollection 2012. Front Oncol. 2012. PMID: 22649779 Free PMC article.
227 results